Senores Pharmaceuticals intimates BSE and NSE of its scheduled analyst and institutional investor meetings on May 25, 2026.
The physical meetings, hosted by Ambit Capital in Mumbai, will involve group and one-on-one discussions starting at 11:00 AM IST.
Company confirms discussions will be based solely on publicly available information with no unpublished price sensitive information to be shared.
Disclosure is made pursuant to SEBI LODR Regulations, specifically Regulation 30(6) read with Schedule III.